Sagitta Biotech

Belgium
Ligny, Wallonia, Belgium, 4031

Company profile

Sagitta Biotech company profile

Sagitta Biotech develops innovative viral vectors aimed at creating efficient vaccines, oncolytic viruses, and gene therapy vectors. The company focuses on addressing unmet needs in the fields of vaccines, oncology, and gene therapy. With a strong scientific background and a dedicated R&D team, Sagitta Biotech is building a robust pipeline to advance healthcare solutions.

Business identity

Contact email
[email protected]
Phone number
+32 4 361 42 35
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Postal code
4031
Country code
BE
Continent
Europe

Capital profile

Funding and company signals

Founders
1

Founders and investors

Founders

Benjamin Damien